Eventi : Webinar
THINK HADROM: discovering Hadrontherapy within Multidisciplinarity
Lun 21 nov 2022 - Mer 15 feb 2023
HIGH TECHNOLOGY, ECONOMIC and ETHICAL SUSTAINABILITY
Monday, November 21st 2022
The webinar will face current methodologies to evaluate the sustainability of Hadrontherapy going through the clinical experiences and the ethical aspects. Given that Hadrontherapy is up-to-date addressed to rare tumors, a multidisciplinary collaboration is of utmost importance for its application both for the patients benefit and for Healthcare Systems. The translational research will give the chance to expand the scientific knowledge on the clinical benefits of Hadrontherapy. Moreover National and International Networks and Cooperations are the keys to build clinical evidence for and to maximize the investment for this innovative technology.
HEAD & NECK TUMORS
Monday, December 12th 2022
The webinar will be focused on the therapeutic management of Head and Neck cancers, with particular regards to the current evidences and future development of particle therapy. . Particle therapy is currently one of the advanced techniques of radiation therapy, increasingly selected thanks to the advantageous physical and biological properties.. Due to the proximity of HNC target volumes to numerous critical structures and the radioresistance of several histologies, nowadays hadrontherapy represents a promising alternative to photon-based therapy. Head and Neck cancers treatment needs a multidisciplinary approach due to the complexity and rarity of the disease. In this setting, future perspectives will explore the possible combination of systemic therapies and Hadrontherapy, defining the role and timing of these new strategies within national and international collaboration.
CHORDOMAS AND CHONDROSARCOMAS
Wednesday, 15th February 2023
The webinar introduces the indication of surgery and hadrontherapy as the treatment of chordomas and chondrosarcomas.
The therapeutic use of protons and carbons has gained significant interest due to advantageous physical and radiobiologic properties compared to photon-based therapy. By taking advantage of these unique properties, carbon ion radiotherapy (CIRT) may allow dose escalation to tumours while reducing radiation dose to adjacent normal tissues. For these reasons, CIRT has emerged as a promising strategy for the treatment of a variety of malignancies including sacral chordomas that have a relatively poor radiosensitivity and are in critical location.
Topics of the webinar will also be the locoregional approach with systemic treatment and the validity of alternative local therapy when surgery or radiotherapy cannot be considered as the appropriate clinical choice.
Scientific Director: Ester Orlandi
Target Audience: Medical oncologists, radiation oncologists, radiologists, general surgeons, maxillofacialsurgeons, neurosurgeon, otolaryngologists, nuclear medicine physicians, neuroradiologists, neurologists, orthopedics, pain therapist, pediatricians, physiotherapists, nutritionists.
Registration: Participation to the webinars is free, places available are limited. Registrations are only available at https://fad.accmed.org/course/info.php?id=1044, they will be accepted in the chronological order of arrival and will be confirmed by e-mail.